The study highlights the mixed feelings that resident physicians express about APP independence laws. On one hand, some view the increased autonomy for APPs as an opportunity for enhanced patient care, while others harbor concerns about the implications for their training and the physician-patient dynamic. By engaging a diverse demographic of resident physicians, the researchers aimed to capture a comprehensive snapshot of the current attitudes towards these evolving structures of healthcare delivery.

One of the primary findings from the research indicates that many residents believe that APPs can provide high-quality care, particularly in primary care settings. The recognition of APPs as key players in managing patient populations is becoming increasingly prevalent among new physicians. Many residents appreciate how APPs can alleviate the burden of patient volume, allowing physicians to concentrate on more complex cases that require their expertise. This perspective suggests an appreciation for teamwork in medical environments and implies a shift toward collaborative models of care.

Conversely, the study reveals apprehensions among residents concerning the autonomy of APPs. A significant number of participants articulated fears that independent APPs could potentially undermine medical training for residents. The concern stems from the belief that as APPs take on more responsibilities, there may be fewer opportunities for residents to acquire essential hands-on experience. This apprehension underscores a fundamental tension within the healthcare system, where efficiency and autonomy occasionally clash with the imperative to train the next generation of physicians effectively.

Furthermore, the research uncovers how geographical and institutional factors influence resident opinions on APP independence. In states where APPs have been granted greater autonomy, residents expressed a greater acceptance of these laws. This phenomenon can be attributed, in part, to the positive experiences they’ve observed in facilities where team-based care is the norm. In contrast, residents from states with more restrictive laws were often less supportive of APP independence, potentially reflecting an ingrained culture resistant to change or unfamiliarity with the collaborative practice.

Communication between physicians and APPs is another focal point of the study. Many residents indicated that effective communication and mutual respect were prerequisites for successful collaboration in patient care. In environments where such communication exists, there appears to be a stronger endorsement of APP independence. However, the lack of clear protocols for interaction can lead to misunderstandings and a lack of trust, prompting some residents to question the potential risks involved with autonomous APP practice.

The nuances of patient care also play a critical role in shaping resident attitudes. Many residents recognize that APPs can deliver competent care, especially in acute scenarios like urgent care and chronic disease management. This realization aligns with the growing body of evidence suggesting that APPs can perform comparably to their physician counterparts in various healthcare settings. Nevertheless, the disparity between perceptions and experiences highlights the need for ongoing dialogue surrounding the roles of APPs in modern medicine.

Additionally, the study emphasizes the importance of educational initiatives to bridge the gap between APPs and resident physicians. Formal training programs that inform residents about the scope of practice and capabilities of APPs may foster a more harmonious professional environment. Understanding the complementary roles of APPs provides residents with a broader perspective on healthcare delivery and can mitigate fears surrounding competition for patient care responsibilities.

Regulatory frameworks governing APP practice also emerged as a critical point of contention within the study. Residents expressed a desire for transparency in legislative changes that affect APP autonomy. As laws are shaped at the state level, providing education on these legislative processes can empower resident physicians to engage constructively with healthcare policy discussions. This engagement is crucial as healthcare evolves and adapts to better meet the needs of diverse patient populations.

The implications of the findings extend beyond personal attitudes; they highlight broader considerations for the medical profession as a whole. As healthcare systems strive for efficiency, the integration of APPs will undoubtedly continue to escalate. The study advocates for an ongoing examination of how these changes impact the training and attitudes of future physicians. By fostering an environment that values collaboration and shared responsibility, the healthcare field can enhance patient care outcomes while nurturing the next generation of medical professionals.

In summation, the research led by Bohler and colleagues offers crucial insights into the attitudes of resident physicians concerning state advanced practice provider independence laws. As the healthcare landscape transforms, understanding these perspectives will be instrumental in shaping future policies and educational frameworks. The findings elucidate the need for a balanced approach that recognizes the essential roles of both APPs and resident physicians. Ultimately, enhancing collaboration and communication between these groups will be key to meeting the complex demands of modern healthcare.

The discourse surrounding APP independence is far from settled; it invites continuous inquiry and discussion. As more healthcare systems begin to embrace the change, ongoing research will be necessary to monitor how these dynamics evolve and influence the quality of care. This evolving narrative underscores the critical imperative for medical education programs to adapt, encouraging a culture of cooperation and innovation that prioritizes patient welfare above all.

As the study unfolds within the broader dialogue of the medical community, it acts as a clarion call for further investigation and collaboration. Every voice within this dialogue — from resident physicians to APPs and lawmakers — plays an integral role in shaping the future of healthcare. Through mutual respect and understanding, the potential for a more efficient, patient-centered system can be realized.

In conclusion, the research on resident physicians’ attitudes toward state advanced practice provider independence laws reveals complex dynamics at play within the healthcare community. As advanced practice roles continue to expand, the exploration of how these changes affect traditional medical training and patient care remains imperative. The collaborative healthcare model holds promise, but it requires a concerted effort from all stakeholders to ensure it delivers on the potential benefits for patients and providers alike.

The ongoing evolution of healthcare systems calls for resilience and adaptability among all medical professions. By fostering an inclusive and informed discourse surrounding APP independence, we can strive toward a healthcare environment that not only meets current clinical demands but also prepares future generations for the challenges ahead.

Subject of Research: Attitudes of Resident Physicians Toward APP Independence Laws

Article Title: Resident Physicians’ Attitudes Towards State Advanced Practice Provider Independence Laws

Article References: Bohler, F., Petrykowski, N., Iskandar, S. et al. Resident Physicians’ Attitudes Towards State Advanced Practice Provider Independence Laws. J GEN INTERN MED (2026). https://doi.org/10.1007/s11606-025-10096-6

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s11606-025-10096-6

Keywords: advanced practice providers, resident physicians, healthcare policy, independence laws, collaborative care, medical training, patient care

At the heart of this transformation lies the unprecedented ability to harness vast amounts of data. Modern pharmaceutical companies are navigating an expansive sea of health data, from patient histories to genomic information. By deploying advanced analytical tools, they can derive actionable insights that tailor drug development processes more closely to patient needs. This convergence of technology and pharmacology paves the way for personalized medicine, where treatments are customized based on the genetic profile of individuals, thereby enhancing efficacy and minimizing adverse reactions.

A particularly striking development is the emergence of artificial intelligence as a catalyst for innovation. Machine learning algorithms can now identify patterns in data that were previously obscured from human analysts. This capability allows researchers to predict patient responses to treatments with greater accuracy, reducing the time and costs associated with clinical trials. Innovation labs are at the forefront of integrating AI into every phase, from drug discovery to post-market surveillance, fostering a new paradigm in healthcare that prioritizes agility and adaptability.

Moreover, these innovation labs are not confined within the walls of pharmaceutical companies; they often collaborate with academic institutions and tech companies. Such partnerships amplify the pool of expertise and resources, enabling more groundbreaking research. These collaborative ecosystems encourage the exchange of ideas and technologies that can expedite the development of novel therapies targeting pressing health issues. The synergy between academia, industry, and technology sectors creates a fertile environment for groundbreaking discoveries that can lead to significant health improvements.

Additionally, innovation labs are playing a crucial role in regulatory affairs, navigating the complex landscape of healthcare regulations. By staying ahead of regulatory trends and engaging early with regulatory bodies, these labs can advocate for frameworks that support innovation while ensuring patient safety. This proactive approach enhances the overall efficiency of the development process and paves the way for quicker access to cutting-edge therapies for patients in need.

There is also a noteworthy aspect of how innovation labs are utilizing digital health technologies to expand the reach and impact of pharmaceutical solutions. Telemedicine, mobile health applications, and wearable devices are increasingly being integrated into treatment protocols. These technologies not only enhance patient engagement but also provide continuous monitoring of health outcomes, allowing for real-time adjustments in treatment plans. By leveraging digital health solutions, pharmaceutical companies can gather more comprehensive data on drug efficacy and safety, ultimately improving patient care.

The push for sustainability in healthcare is another critical issue that innovation labs are addressing. Many pharmaceutical companies are adopting practices that reduce their environmental footprint, such as employing green chemistry principles and rethinking supply chain logistics. By prioritizing sustainable practices, these innovation labs not only respond to regulatory pressures but also align with the growing consumer demand for environmentally friendly healthcare solutions. This shift towards sustainability indicates a broader trend of corporate responsibility seeping into the pharmaceutical sector.

However, the journey toward transformative health solutions is not without challenges. As these labs advance their capabilities, issues of data privacy and security come to the forefront. The increased reliance on data-driven insights necessitates robust frameworks to safeguard sensitive patient information. Striking a balance between innovation and privacy will be vital for maintaining public trust and ensuring that the benefits of technological advancements are not overshadowed by ethical concerns.

Moreover, the complexities of global healthcare disparities cannot be overlooked. While innovation labs have the potential to drive revolutionary changes, equitable access to new therapies remains a significant challenge. Addressing the needs of underrepresented populations and ensuring that advancements in drug development reach diverse groups is crucial for truly transformative healthcare. Pharmaceutical companies are being called upon to prioritize health equity and invest in strategies that democratize access to innovative treatments.

The COVID-19 pandemic has further accelerated the evolution of pharmaceutical innovation. The urgency to respond to a global health crisis has galvanized innovation labs to streamline processes and adopt agile methodologies. As a result, there have been remarkable breakthroughs in vaccine development, exemplifying how challenges can spur innovation. This prevailing mindset, cultivated by the pandemic, may continue to shape the future of drug development, encouraging a focus on speed without sacrificing quality.

Furthermore, the landscape of investment in health technology is shifting dramatically. Investors are increasingly recognizing the potential of innovation labs as engines for growth within the pharmaceutical sector. Venture capital is flowing into biotech startups and health tech innovations that align with the strategic visions of established pharmaceutical companies. This financial backing fuels creativity and exploration, enabling labs to experiment with unconventional ideas that challenge the status quo in healthcare.

In summary, the article by Peralta and Sánchez provides a compelling glimpse into how big pharma’s innovation labs are not merely experimental units but central players in the evolving narrative of healthcare transformation. As these labs integrate cutting-edge technologies, foster collaboration, champion sustainability, and address ethical considerations, they redefine the path toward a more effective and equitable healthcare system. The future of pharmaceuticals lies in the ability to adapt swiftly to new challenges and leverage technological advancements, ensuring that the industry remains responsive to the world’s most pressing health needs.

The revolution underway in pharmaceutical innovation underscores an exciting era for healthcare, marked by possibilities that were once the realm of science fiction. The next decade will likely witness an acceleration of these trends, shaping the health solutions of tomorrow and the very fabric of public health. As the conversation around innovation in healthcare continues to evolve, it is crucial for all stakeholders—pharmaceutical companies, healthcare providers, policymakers, and patients—to engage in dialogues that prioritize progress while safeguarding ethical standards and equitable access.

Subject of Research: Transformation in Pharmaceutical Innovation through Innovation Labs

Article Title: Driving Health Transformation: Big Pharma’s Innovation Labs Revolution

Article References:

Peralta, G., Sánchez, B. Driving health transformation: big pharma’s innovation labs revolution.
Health Res Policy Sys 23, 138 (2025). https://doi.org/10.1186/s12961-025-01415-8

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12961-025-01415-8

Keywords: Pharmaceutical Innovation, Health Transformation, Data Science, AI in Healthcare, Personalized Medicine, Health Equity, Sustainability in Healthcare.

The learning health system is defined as an organizational framework that continuously integrates data and insights gleaned from patient care into the improvement of healthcare practices and outcomes. This model moves away from traditional healthcare delivery, which often operates in silos, and instead advocates for a culture of continuous learning and adaptation. By systematically leveraging patient data, health organizations can potentially provide more personalized care and make informed decisions that ultimately enhance patient outcomes.

Preparing health organizations for the transition to a learning health system involves several complex factors. The team conducted an extensive scoping review, analyzing existing literature on the preparedness of healthcare organizations. They focused on identifying the key determinants that influence readiness, such as leadership support, organizational culture, infrastructure, and workforce training. Their findings highlight the multifaceted nature of adapting to new models of care, which necessitates a comprehensive understanding of both the internal and external environments affecting healthcare organizations.

One of the primary aspects explored by the researchers was the importance of leadership in facilitating the transition to a learning health system. Strong and committed leaders play a vital role in fostering a culture that emphasizes learning, innovation, and patient-centered care. Leadership is instrumental in allocating necessary resources, advocating for change, and ensuring staff engagement throughout the process. This review underscores that without a supportive leadership network, healthcare organizations may struggle to implement learning initiatives effectively.

Another significant factor identified is the role of organizational culture in shaping readiness for implementing a learning health system. A culture that embraces innovation, collaboration, and open communication can significantly enhance the ability of healthcare organizations to adapt to change. Conversely, an ingrained resistance to change can serve as a barrier to progress. The team advocates for strategies that cultivate a positive organizational culture, which aligns with the principles of a learning health system.

Infrastructure is also a cornerstone of readiness. Health organizations must assess their current technological resources and capabilities to support a learning health system. This includes establishing robust data management systems that can collect, analyze, and interpret patient data efficiently. Moreover, as data privacy and security are paramount in healthcare, organizations need to ensure that their infrastructure adheres to regulatory standards while enabling innovative practices.

Workforce training and development emerge as crucial elements in the transition to a learning health system. The researchers pointed out that healthcare professionals must be equipped with the skills to analyze data, engage in collaborative decision-making, and apply evidence-based practices. Continuous education and professional development should be an integral part of the readiness assessment, ensuring that staff remains competent and confident in navigating the evolving healthcare landscape.

The scoping review also sheds light on the significance of patient involvement in the learning health system model. Engaging patients as active partners in their own care can lead to improved health outcomes and enhanced patient satisfaction. The researchers emphasize the need for healthcare organizations to develop strategies that facilitate patient participation in the decision-making process, as this not only empowers patients but also enriches the data ecosystem for learning.

Furthermore, the study highlights the challenges that health organizations may face in the transition process. Factors such as limited financial resources, bureaucratic red tape, and the existing legacy systems could impede progress. Awareness of these obstacles is crucial for stakeholders aiming to implement a learning health system, as it allows them to devise strategies for overcoming these challenges.

In conclusion, Giroux and colleagues’ scoping review serves as a timely reminder of the importance of assessing readiness for implementing a learning health system in healthcare organizations. The intersection of leadership, culture, infrastructure, workforce training, and patient engagement provides a comprehensive framework for organizations to evaluate their preparedness. As the healthcare ecosystem continues to evolve, understanding these dynamics will be essential for fostering innovative practices that improve patient care and outcomes.

Healthcare stakeholders are encouraged to take heed of the findings from this research to ensure that their organizations are adequately prepared for the transition to a learning health system. By doing so, they can not only enhance organizational effectiveness but also ultimately contribute to a more resilient and responsive healthcare system.

Subject of Research: Health organization readiness for implementing a learning health system.

Article Title: Evaluating health organization readiness for implementing a learning health system: a scoping review.

Article References:

Giroux, C.M., Thomas, A., Bussières, A. et al. Evaluating health organization readiness for implementing a learning health system: a scoping review.
Health Res Policy Sys (2025). https://doi.org/10.1186/s12961-025-01432-7

Image Credits: AI Generated

DOI: 10.1186/s12961-025-01432-7

Keywords: Learning health system, health organization readiness, organizational culture, leadership, patient engagement, workforce training, data management.

Professor Binagwaho, a Rwandan pediatrician of remarkable stature, has dedicated her career to addressing disparities in access to healthcare, underscoring the importance of robust health systems particularly within low- and middle-income countries. She co-founded the University of Global Health Equity (UGHE) in 2015, an innovative institution stemming from Partners In Health’s vision to reimagine health professional education globally. This groundbreaking academic model emphasizes a multidisciplinary approach, integrating clinical excellence with social determinants of health to foster a new generation of healthcare leaders equipped to tackle health inequities worldwide.

Her journey is deeply intertwined with the history of Rwanda’s health transformation. After the 1994 Genocide against the Tutsi, Professor Binagwaho returned in 1996 to assist in the urgent reconstruction of the country’s devastated health infrastructure. Throughout her public service career, spanning from Executive Secretary of the National AIDS Control Commission to Minister of Health, she played a pivotal role in implementing policies that not only controlled infectious diseases like HIV/AIDS but also strengthened healthcare delivery systems at every level, enhancing resilience and equity.

Professor Binagwaho’s leadership extended into global platforms such as co-chairing the Millennium Development Goal Task Force on HIV/AIDS and Access to Essential Medicines, addressing one of the most pressing health challenges of the early 21st century. Her academic influence is further broadened through her appointments at UGHE, Harvard Medical School, and Dartmouth’s Geisel School of Medicine—institutions where she contributes to advancing health equity scholarship and fostering collaboration across diverse health systems.

Her governance roles in prominent organizations including the Rockefeller Foundation, African Europe Foundation, Cummings Foundation, and the African Union Commission for Infectious Diseases Response highlight her global engagement and strategic influence in shaping infectious disease policies and health initiatives. These roles enable her to advocate for equitable health solutions across continents, underscoring the interconnectedness of global health challenges and the need for coordinated responses.

With over 250 peer-reviewed publications to her name, Professor Binagwaho’s scholarly work offers evidence-based insights into strengthening healthcare delivery, particularly in resource-constrained environments. Her recognition by prestigious bodies, including membership in the U.S. National Academy of Medicine and fellowships in both the African Academy of Sciences and the World Academy of Sciences, attests to her standing in the international scientific community. Moreover, her accolades such as being named among the 100 Most Influential African Women and receiving the L’Oréal-UNESCO Award for Women in Science signify the profound impact she has made both scientifically and socially.

Her recent lecture at the RCSI award ceremony delved into the mechanics of “Health Equity and Improving Health Systems,” where she emphasized the indispensable role of community engagement in building trustworthy and resilient healthcare services. Drawing on Rwanda’s experience and broader Sub-Saharan African contexts, she articulated how effective health programs are rooted in authentic community involvement, overcoming mistrust, and demystifying health sciences. This approach aligns with contemporary understandings of health systems as complex adaptive systems requiring stakeholder buy-in and culturally tailored interventions.

The award presentation further illuminated RCSI’s ongoing commitment to advancing the United Nations’ Sustainable Development Goal 3, which aims to ensure healthy lives and promote well-being for all ages. RCSI’s School of Population Health continues to expand research that tackles diverse population health challenges ranging from non-communicable diseases like diabetes to environmental factors such as air pollution. This dedication to locally relevant yet globally applicable research strategies reflects the enduring legacy of Sir Charles A. Cameron, whose reforms laid the groundwork for integrated public health.

Professor Cathal Kelly, Vice Chancellor of RCSI, lauded Professor Binagwaho’s embodiment of the equity, compassion, and collaboration at the heart of the Cameron Award. He noted that her visionary leadership in reconstructing Rwanda’s health system and fostering health professional education serves as a compelling model for institutions worldwide committed to health equity. Such leadership is crucial in today’s global health landscape, marked by complex systemic inequities and emergent health threats requiring innovative, inclusive solutions.

RCSI itself remains a frontrunner in medical education and research with a focus on global health impact, as demonstrated by its top-ranking in the Times Higher Education University Impact Rankings 2025 for contributions to SDG 3. The institution’s international outlook is matched by initiatives such as a forthcoming public engagement center in Dublin, designed to bridge scientific discovery and public understanding. This space aims to catalyze health literacy and empower individuals with the knowledge to make informed health choices, reflecting RCSI’s philosophy of community partnership and knowledge dissemination.

In sum, Professor Agnes Binagwaho’s receipt of the Cameron Award underscores a life’s work devoted to systemic improvements in population health through health equity, education, and community-driven healthcare transformation. Her career narrative illustrates the power of integrating clinical expertise, policy leadership, and academic rigor with social justice imperatives, setting a benchmark for global health stewardship in the 21st century. Her example inspires continued efforts to forge resilient health systems that leave no one behind, echoing the foundational values exemplified by Sir Charles A. Cameron over 150 years ago.

Subject of Research: Health equity, health systems strengthening, and global health education in low- and middle-income countries.

Article Title: Professor Agnes Binagwaho Awarded the Cameron Award for Population Health by RCSI

News Publication Date: 3 November 2025

Web References: Not provided

References: Not provided

Image Credits: Not provided

Keywords: Health Equity, Global Health, Public Health Leadership, Health Systems Strengthening, Medical Education, Rwanda, Infectious Diseases, Community Engagement, Sustainable Development Goals, Population Health, Universal Health Coverage, Health Policy

At the forefront of this critical issue is Dr. Dong-Gil Ko, an associate professor at the University of Cincinnati’s Carl H. Lindner College of Business. He is dedicated to innovating a new telehealth billing model that strives to rectify the discrepancies inherent in the current system. In his research published in the Journal of the American Medical Informatics Association, Ko emphasizes the need for a paradigm shift that takes into consideration not just the time physicians invest, but also the cognitive skills and clinical judgment they possess. The core of his argument is that experienced doctors, who can often provide accurate responses swiftly, are penalized in the existing compensation model, potentially disincentivizing a high level of practice quality.

Ko’s assertions are particularly profound given the implications for patient care. The traditional approach allegedly skews compensation towards those who take longer to provide responses, regardless of their expertise. This is troubling when one considers that a newer, less skilled doctor may take more time to analyze a situation, yet end up receiving a higher compensation than a seasoned professional offering rapid and accurate care. The ramifications of this system are multifaceted, affecting not only provider income and morale but also the overall relationship between doctors and patients.

Ko’s collaboration with experts like Dr. Umberto Tachinardi, Chief Health Digital Officer at UC Health, and Dr. Eric J. Warm, an internal medicine physician and researcher, underscores the significance of interdisciplinary approaches to this problem. Together, they are leveraging artificial intelligence and electronic health records to create a framework that values clinicians based on both the time they spend on inquiries and the expertise they offer. This approach marks a significant evolution in thinking about how healthcare providers are compensated in the burgeoning field of telehealth.

Moreover, there’s a pressing need to address systematic discrepancies in reimbursement codes, as outlined in Ohio’s current medical billing code instituted in 2023. Under these guidelines, physicians are compensated based on the time taken to address patient questions through secure messaging platforms, with an extraordinary limit where responses under five minutes go uncompensated. This has led to an inherent bias against experienced providers who may deliver faster service as a result of their training and experience, thus generating a precarious situation that could impede patient-provider interactions.

The limitations of evaluating medical practices solely based on response times are becoming increasingly apparent to stakeholders. As Ko articulates, the present system may jeopardize the trust patients have in their healthcare providers by emphasizing billing decisions based on unfounded time estimates rather than tangible medical outcomes. These concerns lead to questions about the sustainability of such a billing practice, especially as the demand for telehealth services continues to escalate.

In navigating this complexity, Ko envisions a transformative future for telehealth billing. By integrating advanced technologies and innovative research methodologies, he aims to construct a model which not only compensates physicians fairly but also enhances patient care processes. His anticipated AI system could analyze physicians’ interactions to generate nuanced insights into their expertise levels and the complexity of the issues they manage. The ultimate goal is to facilitate equitable compensation that reflects the true value of a clinician’s contribution.

Looking ahead, Ko anticipates that the intersection of generative AI and telehealth will introduce new layers of complexity that necessitate further innovation. As AI tools gain traction in providing initial patient assessments or responses, the role of the physician could evolve to one of validation and enhancement of these technological outputs. This could necessitate more recognition of a doctor’s time spent ensuring that mechanisms are and remain operational, potentially reshaping their workload and compensation standards.

Ko’s pioneering work places him at the vanguard of these crucial changes. He looks forward to launching pilot programs in coordination with healthcare systems in 2025, with the objective of transforming the telehealth compensation framework across Ohio and possibly beyond. His research has the potential to reshape how telehealth practices are funded, creating a more equitable future for healthcare providers and improving the standard of care for patients.

The implications of Ko’s research extend far beyond simple billing practices; it represents a pivotal shift in recognizing the intrinsic value of medical expertise within healthcare delivery. With healthcare rapidly evolving, the necessity for models that fairly compensate all involved in the delivery of care is more pressing than ever.

By positioning himself as a thought leader in this space, Dr. Ko is not just collaborating on technological advancements, but instigating a discourse on the fundamental nature of care in a digital landscape. His work highlights that as healthcare navigates an increasingly virtual future, the equitable recognition of both time and expertise will be essential in maintaining the integrity of patient care.

As Dr. Ko continues to develop this innovative telehealth billing model, he remains committed to ensuring that compensation structures value the evolving roles of healthcare professionals, fostering a system that incentivizes expertise while enhancing patient outcomes. This trajectory reflects a timely and necessary evolution needed in telehealth billing that aligns with contemporary medical practices and healthcare delivery.

Subject of Research: Telehealth billing models
Article Title: Secure messaging telehealth billing in the digital age: moving beyond time-based metrics
News Publication Date: 2-Jan-2025
Web References: Journal of the American Medical Informatics Association
References: Ko, D.-G., Tachinardi, U., Warm, E. J. (2025). Secure messaging telehealth billing in the digital age: moving beyond time-based metrics. Journal of the American Medical Informatics Association.
Image Credits: Photo courtesy of the University of Cincinnati.
Keywords: Telehealth, medical billing, AI in healthcare, healthcare delivery, telemedicine, clinical expertise.